The Amgen Inc. (AMGN) revenue growth is 18.2%, which is lower than the industry median of 18.1% and the 5-year historical average of 6.2%.
The Amgen Inc. (AMGN) operating income growth is (21.1%), compared to the industry median of 33.7% and the 5-year historical average of (6.1%).
The Amgen Inc. (AMGN) EPS growth is (39.3%), compared to the industry median of (12.0%) and the 5-year historical average of (6.7%).
The Amgen Inc. (AMGN) Free Cash Flow growth is 41.2%, compared to the industry median of 15.3% and the 5-year historical average of (2.9%).